The 5-HT(7) receptor and disorders of the nervous system: an overview
by
Hedlund PB.
Department of Molecular Biology,
MB10, The Scripps Research Institute,
10550 North Torrey Pines Road, La Jolla, CA, 92037, USA,
hedlund@scripps.edu.
Psychopharmacology (Berl). 2009 Aug 1.


ABSTRACT

RATIONALE: The 5-HT(7) receptor is a more recently discovered G-protein-coupled receptor for serotonin. The functions and possible clinical relevance of this receptor are not yet fully understood. OBJECTIVE: The present paper reviews to what extent the use of animal models of human psychiatric and neurological disorders have implicated the 5-HT(7) receptor in such disorders. The studies have used a combination of pharmacological and genetic tools targeting the receptor to evaluate effects on behavior. RESULTS: Models of anxiety and schizophrenia have yielded mixed results with no clear role for the 5-HT(7) receptor described in these disorders. Some data are available for epilepsy, migraine, and pain but it is still very early to draw any definitive conclusions. There is a considerable amount of evidence supporting a role for the 5-HT(7) receptor in depression. Both blockade and inactivation of the receptor have resulted in an antidepressant-like profile in models of depression. Supporting evidence has also been obtained in sleep studies. Especially interesting are the augmented effects achieved by combining antidepressants and 5-HT(7) receptor antagonists. The antidepressant effect of amisulpride has been shown to most likely be mediated by the 5-HT(7) receptor. CONCLUSIONS: The use of pharmacological and genetic tools in preclinical animal models strongly supports a role for the 5-HT(7) receptor in depression. Indirect evidence exists showing that 5-HT(7) receptor antagonism is clinically useful in the treatment of depression. Available data also indicate a possible involvement of the 5-HT(7) receptor in anxiety, epilepsy, pain, and schizophrenia.
TCAs
SSRIs
Suicide
Serotonin
Dopamine
Melancholia
Noradrenaline
SSRI spectrum
SSRI mechanisms
Future anxiolytics
MDMA neurotoxicity
21C antidepressants
The serotonin receptors
Serotonin and psychedelics
SNaRIs, NaSSAs, and NaRIs
Serotonin and romantic lovers
Neuropharmacology of serotonin
The monoamine theory of depression
Fluoxetine (Prozac): 10th Anniversary
Serotonin and the genetics of depression
Are SSRI antidepressants little better than placebos?


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family